drug · small molecule
patient view →daridorexant hydrochloride
Marketedupdated 2mo agoby Idorsia Pharmaceutical Ltd🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval, with an approval for insomnia.
targets
Orexin receptor type 2Orexin/Hypocretin receptor type 1
all catalysts(1)
phase 2 completion · 1
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that